Therapeutic efficacy of the α-emitter 211At bound on microspheres compared with 90Y and 32P colloids in a murine intraperitoneal tumor model
- 31 December 1992
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 47 (3), 366-372
- https://doi.org/10.1016/0090-8258(92)90141-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of Ovarian cancerCancer, 1992
- Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trialsInternational Journal of Gynecology & Obstetrics, 1991
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- The effect of the α-emitting radionuclide lead-212 on human ovarian carcinoma: A potential new form of therapyGynecologic Oncology, 1989
- 212Bismuth Linked to an Antipancreatic Carcinoma Antibody: Model for Alpha-Particle-Emitter RadioimmunotherapyJNCI Journal of the National Cancer Institute, 1988
- Limitations to the killing of tumours using radiolabelled antibodiesThe British Journal of Radiology, 1987
- Astatine-211: Its possible applications in cancer therapyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- Long-Term Follow-Up and Prognostic Factors in Ovarian Carcinoma: The Radiumhemmet series 1958 to 1973Acta Radiologica: Oncology, 1982
- The Effect of Oxygen on Impairment of the Proliferative Capacity of Human Cells in Culture by Ionizing Radiations of Different LETInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1966